AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.
about
Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingMeningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningiomaPathology and molecular genetics of meningioma: recent advances.TERT Promoter Mutations and Risk of Recurrence in Meningioma.ARID1A and TERT promoter mutations in dedifferentiated meningioma.Diagnostic Challenges in Meningioma.Genetic landscape of meningioma.SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.The new WHO 2016 classification of brain tumors-what neurosurgeons need to know.Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression.Systemic therapy for recurrent meningioma.High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.Somatic AKT1 mutations cause meningiomas colocalizing with a characteristic pattern of cranial hyperostosis.SMO mutant olfactory groove meningiomas-the next in line for targeted therapy.An overview of meningiomasAntiangiogenic Treatment of Meningiomas
P2860
Q26739662-B1B976E4-A844-4487-A034-CA6D8798EEE8Q26741529-6342EDC1-52E8-42C2-B284-422C0D6C3713Q27853347-5F3C8A1B-EEE1-4D6E-B168-5B4CEDB91CB8Q28550300-760F7B33-7F84-46DD-854E-2B0BE748C908Q35072568-5F86E611-8A75-41AD-84FE-5DA8C2975DADQ35943650-01CF485B-292C-4BC7-9484-AE59F184107EQ36849156-652BB06E-BE4C-4F7F-A154-80BF4EA4AA29Q36942228-2FD7D691-1659-4D87-BE89-B936DE02A9F7Q38680767-839C3FEC-22B7-47A2-B198-EC2FA27C4957Q38953562-B3BCB180-2DF4-47A7-A1F9-1BA9F317A80AQ39023691-CA760234-70FD-4877-9B63-C9EE20D7B722Q39091307-0A7B8E51-8D83-4B83-BB53-A35AC629F90DQ47804450-8E3FF78B-5016-4F7B-ACD1-F176D9A97487Q48109121-7ED2BF0C-6F28-44CC-A6E9-FC3BA2142134Q48120617-EF8530E0-2799-4073-97C7-3C4D8E9D5D59Q48787594-B6366476-B936-4A22-A086-7F62DF20F28FQ48857394-DD54C72C-8430-42DB-8FD1-1D30C371CA77Q50664835-76AFBA2B-1646-4F20-9521-474960D903A8Q52975861-F4279EDC-4C0E-4E07-BCD9-3CB9A40ACFFCQ53971614-C056F0FB-FC7E-4CE4-92C7-EDFCF59219B7Q57163869-2F3123D1-5DC2-4E83-BCBD-7BB9CB100CB8Q58002991-AF7CB8E2-F404-413E-8382-C3E000C30450
P2860
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@en
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@nl
type
label
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@en
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@nl
prefLabel
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@en
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@nl
P2093
P2860
P50
P1476
AKT1E17K mutations cluster wit ...... by SFRP1 immunohistochemistry.
@en
P2093
Albert Becker
Andreas Unterberg
Anna-Sophie Berghoff
Antje Habel
Christian Hartmann
Christian Koelsche
Christian Mawrin
David Reuss
David T W Jones
Jochen Meyer
P2860
P2888
P304
P356
10.1007/S00401-013-1187-5
P50
P577
2013-10-06T00:00:00Z